Chargement en cours...
Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment
PURPOSE: The current study aims to investigate the neurodevelopment of premature infants after intravitreal injections of bevacizumab (IVB) for the treatment of retinopathy of prematurity (ROP) up to the age of 2 years. METHODS: The study design was retrospective observational case series conducted...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4729687/ https://ncbi.nlm.nih.gov/pubmed/26815000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0148019 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|